Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Journal TOC

Aug 27, 2018

All the Latest on Viral Clearance from the 2017 Viral Clearance Symposium

The September/October edition of the PDA Journal of Pharmaceutical Science and Technology features summaries of presentations at the 2017 Viral Clearance Symposium. Topics covered include virus barrier filters, virus filtration and more!

Editorial

  • Richard Levy, “Special Viral Clearance Issue and St Gallen PDA Collaboration Paper“
  • Franz Nothelfer, Stefan Hepbildikler, “Proceedings of the 2017 Viral Clearance Symposium – Introduction“

Review

  • Glen Bolton, Dayue Chen, “Upstream Mitigation Part 1: Cell Bank and Bulk Harvest Testing“
  • Dayue Chen, Glen Bolton, “Session 1.1 Upstream Mitigation Part 2: Virus Barrier Filter and HTST“
  • Thomas Kreil, David Roush, “Proceedings of 2017 Viral Clearance Symposium Session 2.1: DSP Unit Operations – Virus Filtration/ Inactivation“
  • Thomas Kreil, David Roush, “Proceedings of 2017 Viral Clearance Symposium Session 2.2: DDSP Unit Operations – Purification Unit Operations“
  • Johannes Bluemel, Junfen Ma, “Proceedings of 2017 Viral Clearance Symposium Session 3: Resin Life Time“
  • Astrid Schwantes, Qi Chen, Rachel Specht, “Proceedings of 2017 Viral Clearance Symposium Session 4: Submission Strategies“
  • Junfen Ma, Thomas R. Kreill, “Proceedings of 2017 Viral Clearance Symposium Session 5: Facility Risk Mitigation“
  • Sarah Johnson, David Roush, “Proceedings of 2017 Viral Clearance Symposium Session 6: Ensuring Viral Safety in Continuous Processing“

Editorial

  • Stefan Hepbildikler, Sarah Johnson, Johannes Bluemel, “Viral Clearance Symposium 2017 Conclusion“

Research

  • Paul Buess, et al., “The Impact of Quality Culture on Operational Performance – An Empirical Study from the Pharmaceutical Industry“

Conversations

comments powered by Disqus